<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00484523</url>
  </required_header>
  <id_info>
    <org_study_id>2007/09</org_study_id>
    <nct_id>NCT00484523</nct_id>
  </id_info>
  <brief_title>Constitution of a Standardized Neural Imaging Database in Healthy Subjects</brief_title>
  <official_title>Constitution of a Standardized Neural Imaging Database in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <brief_summary>
    <textblock>
      MRI is a powerful imaging tool used for the precise study of brain morphology (morphometric&#xD;
      study, tissue study, study of connectivity).&#xD;
&#xD;
      Isotopic examinations by Single Photon Emission Tomography (SPET) and Positron Emission&#xD;
      Tomography (PET) are used to explore cerebral perfusion metabolism (99mTc- ECD SPET and 18FDG&#xD;
      PET), as well as dopaminergic neurotransmission (123I FP-CIT SPET, DATSCAN®).&#xD;
&#xD;
      These examinations routinely contribute to the clinical diagnosis and surveillance of many&#xD;
      neurological pathologies (dementias, Parkinson syndromes, epilepsies, concussions, vascular&#xD;
      pathology, brain tumors, etc.).&#xD;
&#xD;
      As a result of the original morphological and functional information they provide, these&#xD;
      examinations are being increasingly included in clinical research protocols involving the&#xD;
      brain.&#xD;
&#xD;
      The absolute or relative quantification of anomalies observed, however, can be obtained only&#xD;
      after comparison to a database of normal subjects.&#xD;
&#xD;
      The creation of these databases is currently limited by their cost and strictly single center&#xD;
      nature (physical characteristics of each center's MRI, gamma cameras and PET scanner).&#xD;
&#xD;
      The aim of this multidisciplinary study is to constitute a standardized database of multimode&#xD;
      neural imaging (SPET, PET and MRI) to be able to objectively quantify anomalies observed in&#xD;
      patients, at the scale of a group or an individual, for the diagnosis and surveillance of&#xD;
      neurological diseases.&#xD;
&#xD;
      Participants will be paid €350. 60 healthy subjects between 20 and 80 years of age (30 men&#xD;
      and 30 women) will be recruited over 3 years. 4 examinations will be programmed over 2 days&#xD;
      (one cerebral MRI, on 18FDG PET, one 99mTc-ECD SPET and one DATSCAN®).&#xD;
&#xD;
      The strictly single center character of this study is explained by the variability of the&#xD;
      physical characteristics of the imaging equipment used (MRI, SPET and PET scan) inherent to&#xD;
      each center.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>precise brain morphology</measure>
    <time_frame>two days</time_frame>
  </primary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SPET, PET and MRI</intervention_name>
    <description>60 healthy subjects after a a consultation with a neurologist for wich 4 examinations will be programmed in two days ( 1 cerebral MRI, 1pet scan, 1 spet, 1 datascan</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  no neurological or psychiatric history&#xD;
&#xD;
          -  no serious disease&#xD;
&#xD;
          -  receiving no neurotropic&#xD;
&#xD;
          -  no alcoholism&#xD;
&#xD;
          -  no drug addiction&#xD;
&#xD;
          -  social security cover&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  breast feeding&#xD;
&#xD;
          -  contraindication to MRI, SPET or PET exploration&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric GUEDJ, AHU</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique des Hôpitaux de Marseille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <study_first_submitted>June 8, 2007</study_first_submitted>
  <study_first_submitted_qc>June 8, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2007</study_first_posted>
  <last_update_submitted>August 27, 2014</last_update_submitted>
  <last_update_submitted_qc>August 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>To constitute a standardized database of multimode neural imaging.</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

